Gladstone Capital FY2026: NII Covers $1.98 Distribution, But Non-Accruals Jump to 6.0% of Debt Cost
GLAD is trading near its 52-week low of $16.54 (14% above the low).
Summary
Gladstone Capital earned $2.00 per share of net investment income in FY2026, covering its $1.98 of distributions, but non-accrual loans rose to 6.0% of debt cost and NAV slipped to $20.77 from $21.34.
Key Events · Earnings and Guidance · GLAD
-
FY2026 NII Covers Distribution
Net investment income was $45.1 million, or $2.00 per share, against $1.98 per share of common distributions declared for the year.
-
Non-Accruals Jump to 6.0% of Debt Cost
Five loans — B+T Group, Edge Adhesives, Eegee, Lonestar EMS and WB Xcel — were on non-accrual at $52.9 million cost basis (6.0% of debt cost) and $23.8 million fair value, up from $28.8 million (3.6%) a year earlier.
-
NAV Slips on Unrealized Depreciation
Net unrealized depreciation of $11.5 million left the portfolio at 97.1% of cost and NAV per share at $20.77, down from $21.34 at September 30, 2025.
-
Expenses Up 24% on Interest Cost
Total expenses net of adviser credits rose to $54.4 million from $43.9 million, driven by a $5.0 million increase in interest expense as average Credit Facility borrowings climbed to $170.1 million from $40.2 million.
Analysis · GLAD · Unknown
Net investment income of $2.00 per share covered the $1.98 paid out, so the dividend is still earned — but the credit side deteriorated. Non-accrual loans more than doubled in cost terms to $52.9 million, or 6.0% of debt cost, from $28.8 million (3.6%) a year ago, with Eegee, Lonestar EMS, B+T Group, Edge Adhesives and WB Xcel all on non-accrual. That drove $11.5 million of net unrealized depreciation and pushed NAV down to $20.77 from $21.34. Total expenses net of adviser credits rose 24.0% to $54.4 million, largely on a $5.0 million jump in interest expense as Credit Facility borrowings averaged $170.1 million versus $40.2 million. Balance sheet leverage remains within limits — asset coverage of 212.7% on debt and 189.0% on preferred stock — and the $385.0 million facility has $177.7 million available, so there is no near-term liquidity issue. The stock closed at $19.23 on September 30, a 7.4% discount to NAV, which constrains equity issuance under the 1940 Act.
How filings like this one have moved
In the 30 days to Nov 17, 2026, 38% of the 3791 measured filings Wiseek scored 7 moved their stock by 5% or more by the next session's close. The median move was 0.00%. These are measured outcomes after filings of this importance, not a forecast for this one.
Measured one observation per ticker per day, after exclusions. Current figures: Filing Impact Tracker · open dataset
At the time of this filing, GLAD was trading at $18.87 on NASDAQ in the Unknown sector, with a market capitalization of approximately $426.3M. The 52-week trading range was $16.54 to $21.73. This filing was assessed with negative market sentiment and an importance score of 7 out of 10.